BridgeBio Pharma (BBIO) Non-Current Deffered Revenue (2023 - 2026)
BridgeBio Pharma (BBIO) posted Non-Current Deffered Revenue of $10.42 million for Q2 2026, down 28.9% from $14.67 million a year earlier and down 11.5% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Non-Current Deffered Revenue came in at $13.08 million, down 23.5% from FY2024.
- In prior years, BridgeBio Pharma's Non-Current Deffered Revenue was $17.1 million in FY2024 (+358.7%) and $3.73 million in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Non-Current Deffered Revenue since Q4 2023.
- On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last six quarters, with growth averaging 31.2% over the last seven quarters.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $11.78 million (Q1 2026), $13.08 million (Q4 2025) and $13.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | BridgeBio Pharma | 12.85 Bn | 9.97 Bn | 228.63 Mn | 10.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.42 Mn |
| Mar 31, 2026 | 11.78 Mn |
| Dec 31, 2025 | 13.08 Mn |
| Sep 30, 2025 | 13.13 Mn |
| Jun 30, 2025 | 14.67 Mn |
| Mar 31, 2025 | 17.51 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Jun 30, 2024 | 16.96 Mn |
| Mar 31, 2024 | 19.89 Mn |
| Dec 31, 2023 | 3.73 Mn |
API Access
BridgeBio Pharma Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();